ARTICLE | Clinical News
Benlysta belimumab: Phase III started
April 8, 2013 7:00 AM UTC
GlaxoSmithKline began a double-blind, placebo-controlled Phase III trial to evaluate 10 mg/kg IV Benlysta plus 2 mg/kg oral azathioprine daily in about 400 patients with Wegener's granulomatosis or m...